| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Research and development | 7,993 | 9,050 | ||
| Sales and marketing | 350 | 349 | ||
| General and administrative | 3,160 | 4,120 | ||
| Total operating expenses | 11,503 | 13,519 | ||
| Loss from operations | -11,503 | -13,519 | ||
| Interest and other income | - | 264 | ||
| Change in fair value of warrant liabilities | -287 | -40 | ||
| Interest and other income | 158 | - | ||
| Loss before income taxes | -11,058 | -13,215 | ||
| Provision for income taxes | - | 0 | ||
| Net loss | -11,058 | -13,215 | ||
| Net unrealized income on investments | - | -18 | ||
| Net unrealized income/(loss) on investments | 8 | - | ||
| Other comprehensive income/(loss) | 8 | -18 | ||
| Comprehensive net loss | -11,050 | -13,233 | ||
| Net loss per share of class a and class b common stock, basic (in dollars per share) | -1.86 | - | ||
| Net loss per share of class a and class b common stock, diluted (in dollars per share) | -1.86 | - | ||
| Weighted average shares, basic | 5,954,405 | 5,938,282 | ||
| Weighted average shares, diluted | 5,954,405 | 5,938,282 | ||
Vicarious Surgical Inc. (RBOT-WT)
Vicarious Surgical Inc. (RBOT-WT)